Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Buy
+670,597
New +$7.93M ﹤0.01% 1871
2025
Q2
Sell
-112,524
Closed -$154K 4006
2025
Q1
$154K Buy
112,524
+56,939
+102% +$97.7K ﹤0.01% 3826
2024
Q4
$140K Buy
55,585
+34,657
+166% +$95K ﹤0.01% 3910
2024
Q3
$57.1K Sell
20,928
-152,875
-88% -$431K ﹤0.01% 3876
2024
Q2
$410K Buy
+173,803
New +$375K ﹤0.01% 3487
2024
Q1
Sell
-49,209
Closed -$105K 3883
2023
Q4
$105K Buy
+49,209
New +$104K ﹤0.01% 3810
2023
Q3
Sell
-32,507
Closed -$89.7K 3905
2023
Q2
$89.7K Buy
32,507
+22,332
+219% +$63.6K ﹤0.01% 3827
2023
Q1
$30.6K Buy
+10,175
New +$37K ﹤0.01% 3889

Other funds holding ERAS

Ameriprise's ERAS Position: Q1 2026 in Review

Ameriprise opened a new position in Erasca (ERAS) in Q1 2026: 670,597 shares worth $10.9M. The stake represents ﹤0.01% of the portfolio and ranks #1871 among its holdings. This is a return to the name: Ameriprise previously reported a position in ERAS as recently as Q1 2025.

Ameriprise first reported a position in ERAS in Q1 2023 and has held it in 8 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Ameriprise held 670,597 shares of Erasca worth $10.9M as of Q1 2026.
  • Erasca was a new Ameriprise position in Q1 2026.
  • Erasca made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1871 holding.
  • Ameriprise first reported a position in Erasca in Q1 2023 and has held it in 8 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.